Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission

J Neuroimmunol. 2007 Mar;184(1-2):223-6. doi: 10.1016/j.jneuroim.2006.11.001. Epub 2006 Dec 11.

Abstract

Antibodies against heat shock protein 90beta (Hsp90beta) recognize the antigen on the surface of oligodendrocyte precursor cells and induce a decrease in the oligodendrocyte population of cell cultures. This study investigated the presence of anti-Hsp90beta antibodies in patients with multiple sclerosis (MS) during remission. Anti-Hsp90beta antibodies were detected in the cerebrospinal fluid (CSF) of patients with a specific and sensitive western blot procedure using Hsp90beta from cell membrane fraction. The number of patients with anti-Hsp90beta antibodies detected in the CSF was significantly greater in MS patients than in control patients with other neurological diseases, which included patients with other inflammatory neurological diseases. CSF anti-Hsp90beta antibody levels were significantly higher in MS patients than in control patients. The presence of anti-Hsp90beta antibodies in the CSF of MS patients during remission could suggest a potential pathogenic role for these autoantibodies in MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / cerebrospinal fluid*
  • Blotting, Western / methods
  • Cell Line, Tumor
  • Female
  • HSP90 Heat-Shock Proteins / immunology*
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / immunology
  • Neuroblastoma / pathology

Substances

  • Antibodies
  • HSP90 Heat-Shock Proteins
  • HSP90AB1 protein, human